Literature DB >> 15133629

Pulmonary infiltrates in patients with haematologic malignancies: transbronchial lung biopsy increases the diagnostic yield with respect to neoplastic infiltrates and toxic pneumonitis.

A Mulabecirovic1, P Gaulhofer, H W Auner, H Popper, R Krause, C Hesse, H Sill.   

Abstract

We retrospectively evaluated 107 fiberoptic bronchoscopies with and without transbronchial lung biopsy (TBLB) in 98 consecutive patients with haematologic malignancies and pulmonary infiltrates. Bronchoalveolar lavage (BAL) was performed in 45 and BAL plus TBLB in 62 procedures. There was no procedure-related severe haemorrhage, pneumothorax or death. Infectious aetiology was identified in 26 of 107 (24%), toxic pneumonitis in 17 of 107 (16%) and neoplastic infiltration in 9 of 107 (8.5%) episodes. Combined BAL and TBLB was significantly superior to BAL alone with respect to the diagnosis of neoplastic infiltrates (p=0.008) and toxic pneumonitis (p<0.001) and should therefore be included in the diagnostic work-up of this patient cohort.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15133629     DOI: 10.1007/s00277-004-0876-5

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  8 in total

Review 1.  Diagnostic strategy in cancer patients with acute respiratory failure.

Authors:  Elie Azoulay; Benoît Schlemmer
Journal:  Intensive Care Med       Date:  2006-04-29       Impact factor: 17.440

Review 2.  Bacterial Pneumonia in Patients with Cancer: Novel Risk Factors and Management.

Authors:  Justin L Wong; Scott E Evans
Journal:  Clin Chest Med       Date:  2017-03-01       Impact factor: 2.878

3.  Causes of fever in cancer patients (prospective study over 477 episodes).

Authors:  E Toussaint; E Bahel-Ball; M Vekemans; A Georgala; L Al-Hakak; M Paesmans; M Aoun
Journal:  Support Care Cancer       Date:  2006-03-10       Impact factor: 3.603

4.  Clinical outcomes of extracorporeal membrane oxygenation support in patients with hematologic malignancies.

Authors:  Hye Seon Kang; Chin Kook Rhee; Hea Yon Lee; Young Kyoon Kim; Soon Seog Kwon; Seok Chan Kim; Jong Wook Lee
Journal:  Korean J Intern Med       Date:  2015-06-29       Impact factor: 2.884

5.  Etiologies, diagnostic strategies, and outcomes of diffuse pulmonary infiltrates causing acute respiratory failure in cancer patients: a retrospective observational study.

Authors:  Hongseok Yoo; Gee Young Suh; Byeong-Ho Jeong; So Yeon Lim; Man Pyo Chung; O Jung Kwon; Kyeongman Jeon
Journal:  Crit Care       Date:  2013-07-23       Impact factor: 9.097

Review 6.  Management of neutropenic patients in the intensive care unit (NEWBORNS EXCLUDED) recommendations from an expert panel from the French Intensive Care Society (SRLF) with the French Group for Pediatric Intensive Care Emergencies (GFRUP), the French Society of Anesthesia and Intensive Care (SFAR), the French Society of Hematology (SFH), the French Society for Hospital Hygiene (SF2H), and the French Infectious Diseases Society (SPILF).

Authors:  David Schnell; Elie Azoulay; Dominique Benoit; Benjamin Clouzeau; Pierre Demaret; Stéphane Ducassou; Pierre Frange; Matthieu Lafaurie; Matthieu Legrand; Anne-Pascale Meert; Djamel Mokart; Jérôme Naudin; Frédéric Pene; Antoine Rabbat; Emmanuel Raffoux; Patricia Ribaud; Jean-Christophe Richard; François Vincent; Jean-Ralph Zahar; Michael Darmon
Journal:  Ann Intensive Care       Date:  2016-09-15       Impact factor: 6.925

7.  Efficacy and Safety of Endobronchial Ultrasonography with a Guide-sheath for Acute Pulmonary Lesions in Patients with Haematological Diseases.

Authors:  Kei Nakashima; Masafumi Misawa; Ayumu Otsuki; Kentaro Narita; Yoshihito Otsuka; Kosei Matsue; Masahiro Aoshima
Journal:  Intern Med       Date:  2022-03-01       Impact factor: 1.271

8.  Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).

Authors:  G Maschmeyer; J Carratalà; D Buchheidt; A Hamprecht; C P Heussel; C Kahl; J Lorenz; S Neumann; C Rieger; M Ruhnke; H Salwender; M Schmidt-Hieber; E Azoulay
Journal:  Ann Oncol       Date:  2014-05-15       Impact factor: 32.976

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.